muramylnac-ala-isogln-lys-tripeptide and Bone Neoplasms

muramylnac-ala-isogln-lys-tripeptide has been researched along with Bone Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bernstein, ML; Betcher, D; Conrad, E; Ferguson, W; Gebhardt, M; Goorin, AM; Grier, H; Harris, MB; Healey, J; Huvos, A; Kleinerman, ES; Krailo, M; Link, M; Meyers, PA; Montebello, J; Nadel, H; Nieder, M; Sato, J; Schwartz, CL; Siegal, G; Weiner, M; Wells, R; Wold, L; Womer, R	1
Dubielzig, RR; Fox, LE; Helfand, SC; Keller, ET; Kurzman, ID; MacEwen, EG; Madewell, BR; Rodriguez, CO; Rosenthal, RC; Vail, DM	1

Trials

2 trial(s) available for muramylnac-ala-isogln-lys-tripeptide and Bone Neoplasms

Article	Year
Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Mar-20, Volume: 23, Issue:9 Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Infant; Male; Methotrexate; Osteosarcoma; Prospective Studies	2005
Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin. Clinical cancer research : an official journal of the American Association for Cancer Research, 1995, Volume: 1, Issue:12 Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Dog Diseases; Dogs; Double-Blind Method; Drug Carriers; Female; Liposomes; Male; Osteosarcoma	1995

Article

Year

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Mar-20, Volume: 23, Issue:9

Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Infant; Male; Methotrexate; Osteosarcoma; Prospective Studies

2005

Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin.

Clinical cancer research : an official journal of the American Association for Cancer Research, 1995, Volume: 1, Issue:12

Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Dog Diseases; Dogs; Double-Blind Method; Drug Carriers; Female; Liposomes; Male; Osteosarcoma

1995

Other Studies

1 other study(ies) available for muramylnac-ala-isogln-lys-tripeptide and Bone Neoplasms

Article	Year
A special grant for special patients from the American Cancer Society. Oncology (Williston Park, N.Y.), 1990, Volume: 4, Issue:3 Topics: Acetylmuramyl-Alanyl-Isoglutamine; Bone Neoplasms; Financial Management; Financing, Personal; Fund Raising; Humans; Lung Neoplasms; Osteosarcoma	1990